For instance, a melanoma-derived tumor antigen gp100-expressing VSV (VSV-gp100) combined with adoptive transfer of gp100-specific T cells resulted in increased survival of mice with established melanoma that was accompanied by the development of antitumor T cell responses (34, 35). Here, PMEL is linked to melanoma.